http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04244083-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
filingDate 1991-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c6270ffe8804988eff7fdc4d0279a33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24dbe892108484cca728f4f3d58faf3b
publicationDate 1992-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04244083-A
titleOfInvention Tricyclic pyridone derivative
abstract PURPOSE: To obtain a new tricyclic pyridone derivative useful for controlling or preventing musclar tension, suppression and sleeplessness, etc. n CONSTITUTION: This compound of the formula I or its pharmasceutically acceptable acid added salt of the compound of the formula I having basic substituted group, e.g. N,N-dimethyl-4,6-dihydro-4-oxo-3-phenylpirido [2,1-a] isoindole-1- carboxyamide is obtained preferably by converting the carboxylic acid of the formula II to an active derivative and then allowing it to react with the compound denoted by the formula R'OH. In the formula I, Ra is H, halogen; Rb is OR 1 (R 1 is non-substituted lower alkyl, hydroxy, etc.), HR 2 R 3 (R 2 is H, hydroxy, etc.; R 3 is H, lower alkyl, etc.); C denoted by B, α is >C α -S-CH≡CH-, >C α -CR 4 =CH-CH=CH-, (R 4 is H, F, etc.). In the formula II, C denoted by β, α is >C α -S-CH=CH-, >C α -CH=CH-CH=CH-. n COPYRIGHT: (C)1992,JPO
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015052018-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7244730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006206595-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011093910-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7375236-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4516922-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003516315-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7476688-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4945710-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7304083-B2
priorityDate 1990-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229632658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425154543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229632661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57107120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68720723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235100884

Total number of triples: 46.